Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deblock

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Small Methods|January 10, 2024
From Corrosion Casting to Virtual Dissection: Contrast-Enhanced Vascular Imaging using Hafnium Oxide NanocrystalsEline Goossens, Loren Deblock, Lisa Caboor, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|October 9, 2015
Anti-tumor activity of lipophilic imidazolium salts on select NSCLC cell linesBrian D Wright, Michael C Deblock, Patrick O Wagers, et al.
European Urology|November 18, 2021
Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC TrialGiulia Baciarello, Remy Delva, Gwenaelle Gravis, et al.
Clinical Genitourinary Cancer|March 23, 2021
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 StudyStéphane Culine, Aude Fléchon, Gwenaelle Gravis, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 11, 2017
Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient: 2016 update-executive summaryMichael J Murray, Heidi F DeBlock, Brian L Erstad, et al.
The Lancet. Oncology|April 2, 2016
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 studyFrançois Bertucci, Mahmoud Fekih, Aurélie Autret, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2024
Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapyNicolas Roussot, Guillaume Constantin, Isabelle Desmoulins, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Small Methods|January 10, 2024
From Corrosion Casting to Virtual Dissection: Contrast-Enhanced Vascular Imaging using Hafnium Oxide NanocrystalsEline Goossens, Loren Deblock, Lisa Caboor, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|October 9, 2015
Anti-tumor activity of lipophilic imidazolium salts on select NSCLC cell linesBrian D Wright, Michael C Deblock, Patrick O Wagers, et al.
European Urology|November 18, 2021
Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC TrialGiulia Baciarello, Remy Delva, Gwenaelle Gravis, et al.
Clinical Genitourinary Cancer|March 23, 2021
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 StudyStéphane Culine, Aude Fléchon, Gwenaelle Gravis, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 11, 2017
Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient: 2016 update-executive summaryMichael J Murray, Heidi F DeBlock, Brian L Erstad, et al.
The Lancet. Oncology|April 2, 2016
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 studyFrançois Bertucci, Mahmoud Fekih, Aurélie Autret, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2024
Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapyNicolas Roussot, Guillaume Constantin, Isabelle Desmoulins, et al.
Pageof 17